HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haifeng Zhu Selected Research

DMC-BH

1/2020Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haifeng Zhu Research Topics

Disease

7Neoplasms (Cancer)
01/2022 - 12/2011
4Glioma (Gliomas)
10/2020 - 12/2011
3Melanoma (Melanoma, Malignant)
01/2022 - 01/2018
3Glioblastoma (Glioblastoma Multiforme)
09/2021 - 11/2018
2Infections
02/2022 - 10/2021
2Osteoarthritis
01/2021 - 08/2020
2Lymphoma (Lymphomas)
06/2013 - 05/2013
2Wounds and Injuries (Trauma)
09/2008 - 04/2007
2Burns
09/2008 - 04/2007
1Bites and Stings (Sting)
03/2022
1Intervertebral Disc Degeneration
03/2022
1Inflammation (Inflammations)
03/2022
1Disease Resistance
07/2021
1Cholelithiasis
05/2021
1Hematoma
03/2020
1Hypertensive Intracranial Hemorrhage
03/2020
1Insulin Resistance
01/2020
1Hodgkin Disease (Hodgkin's Disease)
01/2020
1Arteriovenous Malformations (Arteriovenous Malformation)
03/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
11/2018
1Disease Progression
01/2018
1Fever (Fevers)
01/2018
1Headache (Headaches)
01/2018
1Chills
01/2018
1Radiculopathy (Radiculopathy, Cervical)
01/2018
1Spinal Cord Diseases
01/2018
1Hypertension (High Blood Pressure)
09/2017
1Colorectal Neoplasms (Colorectal Cancer)
08/2017
1Stroke (Strokes)
02/2016
1Pathologic Constriction (Stenosis)
02/2016
1Hepatocellular Carcinoma (Hepatoma)
05/2015
1Stomach Neoplasms (Stomach Cancer)
01/2015
1Carcinogenesis
01/2014
1Liver Neoplasms (Liver Cancer)
01/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2013
1T-Cell Lymphoma (Lymphoma, T Cell)
05/2013

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2013
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2018
2Long Noncoding RNAIBA
01/2022 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
2Messenger RNA (mRNA)IBA
01/2014 - 05/2013
2ProcollagenIBA
09/2008 - 04/2007
2CollagenIBA
09/2008 - 04/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2008 - 04/2007
1Hyaluronic Acid (Hyaluronan)IBA
03/2022
1Poly(amidoamine)IBA
03/2022
1Schiff Bases (Schiff Base)IBA
03/2022
1Small Interfering RNA (siRNA)IBA
03/2022
1AldehydesIBA
03/2022
1HydrogelsIBA
03/2022
1Anti-Bacterial Agents (Antibiotics)IBA
02/2022
1fascaplysineIBA
02/2022
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
10/2021
1ethyleneIBA
10/2021
1jasmonic acid (jasmonate)IBA
10/2021
1EphA1 Receptor (Eph Receptor)IBA
09/2021
1Biological ProductsIBA
09/2021
1RNA (Ribonucleic Acid)IBA
09/2021
1Circular RNAIBA
09/2021
1Transcription Factors (Transcription Factor)IBA
07/2021
1ApolipoproteinsIBA
05/2021
1Apolipoproteins B (ApoB)IBA
05/2021
1isovitexinIBA
01/2021
1epidermal growth factor receptor VIIIIBA
10/2020
1dioscinIBA
08/2020
1Therapeutic UsesIBA
03/2020
1N 30IBA
03/2020
1demethoxycurcuminIBA
01/2020
1Competitive Endogenous RNAIBA
01/2020
1DMC-BHIBA
01/2020
1A Kinase Anchor ProteinsIBA
01/2020
1Thymidine KinaseIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1Leptin ReceptorsIBA
01/2018
1dabrafenibIBA
01/2018
1trametinibIBA
01/2018
1LeptinIBA
01/2018
1Propofol (Diprivan)FDA LinkGeneric
09/2017
1DexmedetomidineFDA Link
09/2017
1PH.3IBA
09/2017
1Cadherins (E-Cadherin)IBA
01/2015
1DecitabineFDA Link
01/2015
1NucleolinIBA
06/2013
1Cell ExtractsIBA
06/2013
1LigandsIBA
06/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2013
1Free RadicalsIBA
05/2013
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
05/2013
1Anaplastic Lymphoma KinaseIBA
05/2013
1Soluble Guanylyl CyclaseIBA
12/2011
1zaprinastIBA
12/2011
1EnzymesIBA
12/2011

Therapy/Procedure

7Therapeutics
03/2022 - 12/2011
2Drug Therapy (Chemotherapy)
05/2015 - 12/2011
1Punctures
03/2022
1Injections
03/2022
1Aftercare (After-Treatment)
03/2020
1Craniotomy
03/2019
1Chemoradiotherapy
11/2018
1Radiotherapy
12/2011